Editorial – Healthcare Worker Stress and Burnout in the time of COVID-19: A Call for Action

This is an Editorial and does not have an abstract. Please download the PDF or view the article HTML

Long-term protection of hepatitis B vaccination among Egyptian children

Background: Hepatitis B Vaccination is the most effective way to prevent transmission of hepatitis B virus (HBV). Objective: to detect the long-term immunogenicity of the vaccine in Egyptian children after five and ten years of vaccination. Methods: Two hundreds healthy children were recruited. They were divided into two groups according to their age. Group A included 100 child, around 6 years old, vaccinated 5 years ago. Group `B` included 100 child, around 11 years old, vaccinated 10 years ago. Hepatitis B surface antibody (HBsAb) titre was tested, booster dose of the vaccine was given to children whose HBsAb was < 10 mIU/ml, then one and half month later, they were retested for HBsAb to evaluate the response. Results: Both groups had a wide range of HBsAb (2-1000 mlU/ml), and there was a significant difference in the level of the two groups. Our data proves the decline of antibody titre with time. In group A, 19 children needed a booster dose, 14 of them were vaccinated, and 10 were retested after one and half month. The results showed that 9 (90%) responded by increased level of HBsAb, with six (66.6%) showing an adequate response. In group B, 52 children had antibody titre < 10, 48 of them were vaccinated and 34 were retested one and half months later. Two out of the 34 did not respond and 32 (94.2%) responded by an increase in the antibody titre. Of those who responded, 19 had adequate response (HBsAb ≥ 100) and 13 had hypo-response (HBsAb = 10 -100). Eighty percent (80%) of boys versus 51.7% of girls responded adequately. Conclusion: Hepatitis B vaccine is an effective and successful way for preventing HBV infection. No need for booster dose at least for 5 years after vaccination .Keywords: HBV- HB vaccine- long term immunityEgypt J Pediatr Allergy Immunol 2011;9(1):35-4

Novel synthesis, ring transformation and anticancer activity of 1,3-thiazine, pyrimidine and triazolo[1,5-a]pyrimidine derivatives

Synthesis, heterocyclization and anticancer activity of a new series of heterocyclic compounds are described. Aminothiazine 1 was obtained from the base induced condensation of thiourea, benzaldehyde and ethyl cyanoacetate. The synthesis of N-phenyl amino pyrimidine derivative 2 was obtained as a result of reaction of aniline with compound 1. Compound 2 underwent ring opening and recyclization upon reaction with HCl or H2O2/ NaOH to afford the acid derivative 3 or oxazine 4, respectively. Thiazine 1 undergoes ring transformation upon the effect of NH2OH.HCl to produce pyrimidine derivative 5. Heterocyclization of compound 1 with thiosemicarbazide followed by oxidation with I2/AcOH afforded triazolopyrimidine 6 and 7, respectively. Alkylation of compound 1 was promoted by reaction of 1 with ethyl iodide to give alkylated thiazine 8 which in turn undergo ring transformation when subjected to reaction with hydrazine hydrate to give pyrazole derivative 9. Refluxing of amino-1,3-thiazine derivative 1 with ethyl bromoacetate in the presence of Et3N produce the alkylated pyrimidine product 10. Hydrazonolysis of 1,3-thiazine 1 with hydrazine or phenyhydrazine gave pyrimidine derivatives 11a,b, respectively. Compound 11b was cyclized with carbon disulfide or formaldehyde to produce triazolopyrimidines 12 and 13, respectively. Some of the new compounds were screened for anticancer activity and significant results were found for some compounds.               KEY WORDS: 1,3-Thiazine, Pyrimidine, Triazole, Pyrazole, Anticancer activity Bull. Chem. Soc. Ethiop. 2018, 32(3), 513-522.DOI: https://dx.doi.org/10.4314/bcse.v32i3.1

Simulation: Early Detection of Brain Vessels Stroke by Applying Electromagnetic Waves Non-Invasively

Introduction: Early recognition of stroke with its two types Ischemic and Hemorrhagic, is one of the most crucial research points, commonly used methods are CT- (computerized tomography), and MRI- (Magnetic resonance imaging). These techniques cause a delay in the detection of the condition, which causes permanent disability. The main reason behind the fatal consequences of stroke is the delay of detection. Therefore, this research paper aims to early detection of the type of stroke without delay until the appropriate diagnosis of each type is made, and then the appropriate treatment without delay. Method: Using a non-invasive and fast technique to determine the stroke type by wave, we simulate and design a vessel containing a liquid as a laminar flow with the same density and velocity of blood, and it was surrounded by a Homogenized multi-turn coil consisting of (n) turns to represent the magnetic field, using specific frequency (HZ) with Electrical field in coil current (A) to see the changing in magnetic flux density (MFD), Depending on the changes in MFD, the flow of blood in laminar flow can be affected by clotting (Ischemic) or Hemorrhagic (cutting) in our vessel designed. We have built three different scenarios to apply the technique which are: First: Normal Scenario (where the blood in vessel has no problem), second: clotting (ischemic, where the vessel blocked in specific three position) and Third: Cutting (Hemorrhagic, where the vessel cut in certain nine positions). Results: This paper presents-through our own design-the studying of applying the electromagnetic waves on blood inside the vessel to detect the stroke type in our three scenarios (normal, ischemic three positions or hemorrhagic nine positions), Studying the magnetic field and laminar flow. This study covered in three areas. First: coil geometry analysis, Second: stationary, and Third: frequency domain. through the changes in Magnetic Flux Density -MFD- waves. The results were promising and distinct for distinguishing between the three scenarios which are normal, ischemic (3 positions) and hemorrhagic (9 positions) the results of MFD are: 0.09 to 3.3*10^-3, 0.08 to 3.15*10^-4, 0.15 to 6.2*10^-3 respectively

Induciranje pluripotentnih matičnih stanica upotrebom mRNA: učinak valproične kiseline, 5-azacitidina i askorbinske kiseline

In the bourgeoning fields of tissue engineering and regenerative medicine, induced pluripotent stem cells (iPSCs) technology with gene therapy are promising candidates for alternative stem cell source and cell transplantation. In this study, small molecules as anti-oxidant; ascorbic acid (ASA), histone deacetylase inhibitors (HDACi); Valproic acid (VPA), and DNA methyltransferase inhibitors (DNMTi); 5-Azacytidine (5-AzaC) were examined during the generation of murine iPSCs using mRNA of Yamanaka factors from mouse embryonic fibroblasts (MEFs). These modulators were selected based on their well-known effect on the epigenetic status and chromatin modification during early reprogramming. iPSC generation was performed by using synthesized mRNAs of Yamanaka factors Oct4, Sox2, c-Myc, and Klf4 (OSCK) as a standard reprogramming strategy. Both morphological changes and the expression level of the pluripotency markers were examined. 5-AzaC with 1 μM concentration has a slightly toxic effect on the cells, affecting its proliferation and growing efficiency. In contrast, the use of VPA or ASA led to a two-fold increase in the number of iPSC colonies. The iPSCs cultured with the addition of VPA or ASA showed a high expression of the tested pluripotency markers, with a significant increase, more than that of the cells cultured with the addition of 5-AzaC. These findings shed light on the role of ASA, VPA, and 5-AzaC during murine iPSCs generation using a mRNA reprogramming strategy.Ubrzani razvoj u područjima tkivnog inženjerstva i regenerativne medicine, potaknuo je tehnologiju pluripotentnih matičnih stanica (iPSCs) koja zajedno s genskom terapijom predstavlja obečavajući izvor matičnih odnosno transplantacijskih stanica. U ovom su radu, za vrijeme stvaranja mišjih iPSC-a upotrebom mRNA Yamanaka faktora od mišjih embrionalnih fibroblasta (MEF), istraženi učinci različitih modulatora: malih molekula kao antioksidansa, askorbinske kiseline (ASA), inhibitora histonske deacetilaze (HDACi), valproične kiseline (VPA), inhibitora DNA metiltransferaze (DNMTi) i 5-azacitidina (5-AzaC). Ovi su modulatori odabrani zbog njihova dobro poznatog učinka na epigenetski status i modifikaciju kromatina za vrijeme ranog reprogramiranja. Stvaranje iPSC-a postignuto je upotrebom sintetiziranih mRNA Yamanaka faktora Oct4, Sox2, c-Myc i Klf4 (OSCK). Istražene su i morfološke promjene i razina ekspresije markera pluripotencije. 5-AzaC s koncentracijom od 1 μM imao je mali toksičan učinak na stanice, utječući na proliferaciju i njihov rast. Nasuprot tome, upotreba VPA-a ili ASA-e dovela je do dvostrukog povećanja broja iPSC kolonija. iPSC kultura s dodatkom VPA-a ili ASA-e pokazala je visoku ekspresiju testiranih markera pluripotencije, sa znakovitim višom razinom u odnosu na stanice kojima je dodan 5-AzaC. Ovi rezultati rasvjetljuju ulogu ASA-e, VPA-a i 5-AzaC-a za vrijeme stvaranja mišjih iPSC-a primjenom strategije reprogramiranja mRNA